Parnassus Endeavor Fund Buys Gap Inc, Regeneron Pharmaceuticals Inc, Perrigo Co PLC, Sells Mattel Inc, Alphabet Inc, Celgene Corp

• New Purchases: GPS, ALK,
• Added Positions: REGN, PRGO, BIIB, ADS,
• Reduced Positions: GOOGL, CMI, AXP, ABBV, AAPL, IPGP, HBI, GILD,
• Sold Out: MAT, CELG, SBUX, AGN,

For the details of Parnassus Endeavor Fund's stock buys and sells, go to https://www.gurufocus.com/guru/parnassus+endeavor+fund/current-portfolio/portfolioportfolio

1. Applied Materials Inc (AMAT) - 6,700,000 shares, 8.56% of the total portfolio.
2. Micron Technology Inc (MU) - 6,400,000 shares, 7.03% of the total portfolio.
3. Biogen Inc (BIIB) - 925,000 shares, 6.15% of the total portfolio. Shares added by 46.83%
4. Lam Research Corp (LRCX) - 1,100,000 shares, 5.88% of the total portfolio.
5. Gilead Sciences Inc (GILD) - 3,000,000 shares, 5.77% of the total portfolio. Shares reduced by 3.23%

Parnassus Endeavor Fund initiated holding in Gap Inc. The purchase prices were between $17.49 and $26.73, with an estimated average price of $22.46. The stock is now traded at around $19.21. The impact to a portfolio due to this purchase was 4.45%. The holding were 8,700,000 shares as of .

Parnassus Endeavor Fund initiated holding in Alaska Air Group Inc. The purchase prices were between $57.32 and $63.91, with an estimated average price of $60.84. The stock is now traded at around $65.13. The impact to a portfolio due to this purchase was 1.45%. The holding were 800,000 shares as of .

Parnassus Endeavor Fund added to a holding in Regeneron Pharmaceuticals Inc by 290.63%. The purchase prices were between $299.6 and $414.82, with an estimated average price of $332.61. The stock is now traded at around $298.28. The impact to a portfolio due to this purchase was 4.14%. The holding were 625,000 shares as of .

Parnassus Endeavor Fund added to a holding in Perrigo Co PLC by 89.74%. The purchase prices were between $42.02 and $52.62, with an estimated average price of $47.64. The stock is now traded at around $50.73. The impact to a portfolio due to this purchase was 2.37%. The holding were 3,700,000 shares as of .

Parnassus Endeavor Fund added to a holding in Biogen Inc by 46.83%. The purchase prices were between $219.29 and $241.72, with an estimated average price of $230.78. The stock is now traded at around $233.14. The impact to a portfolio due to this purchase was 1.96%. The holding were 925,000 shares as of .

Parnassus Endeavor Fund sold out a holding in Mattel Inc. The sale prices were between $9.65 and $13.6, with an estimated average price of $11.74.

Parnassus Endeavor Fund sold out a holding in Celgene Corp. The sale prices were between $92.35 and $98.91, with an estimated average price of $94.95.

Parnassus Endeavor Fund sold out a holding in Starbucks Corp. The sale prices were between $73.96 and $84.69, with an estimated average price of $78.35.

Parnassus Endeavor Fund sold out a holding in Allergan PLC. The sale prices were between $115.73 and $167.43, with an estimated average price of $138.45.

Parnassus Endeavor Fund reduced to a holding in Alphabet Inc by 60%. The sale prices were between $1038.74 and $1296.2, with an estimated average price of $1158.78. The stock is now traded at around $1152.40. The impact to a portfolio due to this sale was -2.35%. Parnassus Endeavor Fund still held 50,000 shares as of .

Parnassus Endeavor Fund reduced to a holding in Cummins Inc by 35.17%. The sale prices were between $150.76 and $171.6, with an estimated average price of $163.72. The stock is now traded at around $171.96. The impact to a portfolio due to this sale was -2.21%. Parnassus Endeavor Fund still held 972,500 shares as of .

Parnassus Endeavor Fund reduced to a holding in American Express Co by 49.46%. The sale prices were between $109.85 and $124.92, with an estimated average price of $117.43. The stock is now traded at around $128.04. The impact to a portfolio due to this sale was -1.99%. Parnassus Endeavor Fund still held 700,000 shares as of .

Parnassus Endeavor Fund reduced to a holding in AbbVie Inc by 48.24%. The sale prices were between $65.7 and $83.98, with an estimated average price of $78.61. The stock is now traded at around $69.53. The impact to a portfolio due to this sale was -1.76%. Parnassus Endeavor Fund still held 880,000 shares as of .

Parnassus Endeavor Fund reduced to a holding in Apple Inc by 37.5%. The sale prices were between $173.3 and $211.75, with an estimated average price of $194.79. The stock is now traded at around $204.15. The impact to a portfolio due to this sale was -0.76%. Parnassus Endeavor Fund still held 250,000 shares as of .